VolitionRx Limited Long-Term Debt, Maturity, after Year Five
VolitionRx Limited (VNRX) had Long-Term Debt, Maturity, after Year Five of $8.55 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2026-08-13
- 2026-06-30: Long-Term Debt, Maturity, after Year Five $8.55M.
- 2026-03-31: Long-Term Debt, Maturity, after Year Five $8.83M.
- 2025-12-31: Long-Term Debt, Maturity, after Year Five $8.00M.
- 2025-09-30: Long-Term Debt, Maturity, after Year Five $7.75M.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2026-06-30 | $8.55M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.83M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $8.00M 10-K · filed 2026-03-31 |
| 2025-09-30 | $7.75M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $8.10M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $7.73M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $5.86M 10-K · filed 2025-03-31 |
| 2024-09-30 | $5.88M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $5.98M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $5.43M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $5.79M 10-K · filed 2024-03-25 |
| 2023-09-30 | $440.74K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $454.52K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $452.63K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $4.32M 10-K · filed 2023-03-15 |
| 2022-09-30 | $527.86K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $564.41K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $598.39K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $3.43M 10-K · filed 2022-03-30 |
| 2021-09-30 | $3.13M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $3.42M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.64M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $3.92M 10-K · filed 2021-03-22 |
| 2020-09-30 | $2.86M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.88M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.97M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.16M 10-K · filed 2020-02-20 |
| 2019-09-30 | $2.55M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $2.79M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $2.53M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.69M 10-K · filed 2019-03-13 |
| 2018-09-30 | $2.49M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.56M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $2.01M 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |